IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
about
The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast.Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.Biological Role and Therapeutic Potential of IDH Mutations in Cancer.
P2860
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@en
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@nl
type
label
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@en
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@nl
prefLabel
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@en
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@nl
P2093
P2860
P50
P1433
P1476
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
@en
P2093
A John Iafrate
Achim A Jungbluth
Ashwini Raghavendra
Benjamin L McCalip
Britta Weigelt
Felipe C Geyer
Fresia Pareja
Gabrielle M Baker
P2860
P304
P356
10.1158/0008-5472.CAN-16-0298
P407
P50
P577
2016-10-20T00:00:00Z